A Agilent Technologies Inc.

Agilent 2022 Early Career Professor Award Presented to Stefanos Nikolaidis

(NYSE: A) announced today that has received the Agilent 2022 Early Career Professor Award. Dr. Stefanos Nikolaidis is an Assistant Professor of Computer Science at the University of Southern California | USC Viterbi School of Engineering and leads the Interactive and Collaborative Autonomous Robotics Systems (ICAROS) lab.

Dr. Chong Wing Yung, Associate Director of University Relations and External Research at Agilent, manages the award program and determined the focus of this year’s award towards contributions to the development of Artificial Intelligence and Machine Vision technologies for intuitive Collaborative Robots (Cobots) to address demands for a flexible next-generation workforce in manufacturing applications.

The Nikolaidis ICAROS lab focuses on technologies that enable cobots to interact robustly with users in unconstrained and dynamic environments. This combination of computational human-robot interaction and automatic scenario generation will enable fundamental advances in developing interactive robots that can assist users in complex, real-world tasks.

“We are thrilled that Professor Nikolaidis has been recognized with the 2022 Agilent Early Career Professor Award, placing him as the preeminent early career faculty in the world in this area,” said Yannis C. Yortsos, Dean of the USC Viterbi School of Engineering. “We are not surprised with this selection given Professor Nikolaidis’ expertise and accomplishments in AI and robotics and how these will help advance manufacturing in today’s rapidly changing technology landscape. Support from this award will allow him to develop his research program further and to explore new and exciting applications of AI and machine vision technologies.”

“Agilent is excited to leverage the prestigious Agilent Early Career Professor Award to support the development of intuitive collaborative robot technologies,” said Dr. Nahid Chalyavi, Associate Vice President of University Relations and External Research at Agilent. “The scientific advances will boost Agilent’s manufacturing capabilities and bring future innovations to our analytical instruments and lab automation equipment.”

Dr. Nikolaidis was selected as the 2022 recipient because of his focus on developing next-generation intuitive, cobots which can augment and enhance human capabilities with superior strength, accuracy and precision, and data capabilities. The COVID-19 pandemic disrupted global supply chains, thus the availability of parts and on-time delivery of scientific instruments. Investing in intuitive automated cobots will add to and enhance Agilent’s world-class manufacturing applications and processes and ensure that Agilent can fulfill its commitment to supplying instruments that our customers trust on time and with uncompromised quality.

The Agilent Early Career Professor Award is an annual program that recognizes and supports promising research from professors who, early in their careers, show outstanding potential for future research in areas of importance to the communities Agilent serves. This award underscores Agilent's commitment to furthering research through the company's products and services, financial support, and collaborative engagement by Agilent scientists and engineers. Further information about the program is available at .

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, please subscribe to the Agilent . Follow Agilent on , , and .

EN
27/07/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approva...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ , a recently approved CAR T therapy. Agilent's advanced cell analysis instrumentation, specifically the technology, was applied in developing and validating AUCATZYL. The xCELLigence RTCA technology supported the development and implementation of the potency assay. By providing precise and reliable cell analysis solutions, Agilent assisted Autolus in achieving the high standards required for FDA approval. Dr. Xiaobo Wang, Vice President and General Manager of the Cell Functio...

 PRESS RELEASE

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital P...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph. The updated release reads: AGILENT TO SHOWCASE NEXT-GENERATION DIGITAL PATHOLOGY SOLUTIONS AT USCAP 2025 (NYSE: A) is excited to announce its participation at the upcoming , which will be held March 22-27, 2025, in Boston. At the conference, Agilent will highlight innovative digital pathology solutions designed to enhance diagnostic accuracy and efficiency. In pathology, Agilent offers comprehensive tissue diagnostic solutions for analyzi...

 PRESS RELEASE

Agilent Research Catalyst Award Presented to Columbia University for P...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced that has received an Agilent Research Catalyst (ARC) Award on behalf of , an internationally recognized researcher and physician-scientist specializing in bone marrow transplant (BMT) and cancer cellular immunotherapy. Dr. Muranski is the Director of Cellular Immunotherapy Laboratory at Columbia University Irving Medical Center. He is also an Assistant Professor of Medicine at Columbia University Medical Center, a principal investigator at the Columbia Center for Translational Immunology (CCTI), and a member of the Herbert Irv...

 PRESS RELEASE

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Com...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced its kit has received two new companion diagnostic indications approvals under EU IVDR1, expanding the eligibility of treatment to early-stage non-small cell lung cancer (NSCLC) and previously untreated advanced melanoma patients. These two new indications bring the total indications launched in Europe for PD-L1 IHC 28-8 pharmDx to nine. PD-L1 IHC 28-8 pharmDx is approved for exclusive use with the advanced staining solution. Lung cancer and malignant melanoma are major healthcare concerns worldwide, with lung cancer accountin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch